Workflow
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Core Insights - Beyond Air, Inc. has established Vanderbilt University Medical Center (VUMC) as its first luminary site to evaluate and promote the clinical and operational benefits of its LungFit® PH device, which utilizes tankless nitric oxide (iNO) technology [1][3] - The collaboration aims to enhance hospital-based nitric oxide therapy and optimize LungFit products through VUMC's advanced research and clinical excellence [2] Company Overview - Beyond Air is a commercial-stage medical device and biopharmaceutical company focused on using nitric oxide to improve patient outcomes in respiratory illnesses, neurological disorders, and solid tumors [5] - The company has received FDA approval and CE Mark for its LungFit PH system, which is designed for treating term and near-term neonates with hypoxic respiratory failure [5] Product Details - LungFit PH generates nitric oxide from room air, eliminating the need for traditional high-pressure cylinders, thus streamlining operations and enhancing efficiency in hospital settings [3][7] - The device can deliver nitric oxide at concentrations ranging from 1 ppm to 80 ppm, with potential applications in treating severe acute lung infections and chronic lung infections [7][8] Strategic Importance - The partnership with VUMC is seen as a significant step for Beyond Air, allowing the company to demonstrate the full utility of its technology to healthcare professionals and potential customers [3] - VUMC's commitment to medical innovation positions it as an ideal partner for Beyond Air in advancing iNO technology and delivery systems [3]